Results 91 to 100 of about 4,370 (170)

Discovery of 2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one derivatives as possible antileishmanial agents. [PDF]

RSC Med Chem, 2022
Seth A, Ghoshal A, Dewaker V, Rani A, Singh SP, Dutta M, Katiyar S, Singh SK, Rashid M, Wahajuddin M, Kar S, Srivastava AK.   +11 more
europepmc   +1 more source

Echinops kebericho Mesfin: A comprehensive review of its ethnopharmacology, phytochemistry, and pharmacological activity

Phytomedicine Plus
Echinops kebericho Mesfin is a medicinal plant endemic to Ethiopia, primarily found in the highland regions. Traditionally, it has been used to treat a wide range of ailments. Despite its extensive ethnopharmacological use, scientific investigations into
Getaneh Worku Moges, Melesse Ababay Assege, Gizachew Mulugeta Manahelohe, Ayalew Temesgen Wodajo, Hailemichael Tegenu Gebrie, Desta Shumuye Meshesha, Shewaye Lakew Mekuria, Birhanu Ayalew Tebeje, Desilal Kokebie Molla, Aderaw Anteneh Belew   +9 more
doaj   +1 more source

Identification of Chalcone Derivatives as Inhibitors of Leishmania infantum Arginase and Promising Antileishmanial Agents. [PDF]

Front Chem, 2020
Garcia AR, Oliveira DMP, Jesus JB, Souza AMT, Sodero ACR, Vermelho AB, Leal ICR, Souza ROMA, Miranda LSM, Pinheiro AS, Rodrigues IA.   +10 more
europepmc   +1 more source

Parallel solution synthesis of lavendustin analogs as antileishmanial agents

ARKIVOC, 2011
Diego G. Ghiano, Paulo B. Carvalho, Babu L. Tekwani, Mitchell A. Avery, Guillermo Labadie   +4 more
doaj   +1 more source

Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents. [PDF]

RSC Med Chem, 2020
Koovits PJ, Dessoy MA, Matheeussen A, Maes L, Caljon G, Ferreira LLG, Chelucci RC, Michelan-Duarte S, Andricopulo AD, Campbell S, Kratz JM, Mowbray CE, Dias LC.   +12 more
europepmc   +1 more source

7-Prenyloxycoumarins as Promising Antileishmanial Agents: In Vitro, In Vivo, and In Silico Evaluation Against <i>Leishmania amazonensis</i>. [PDF]

Pharmaceuticals (Basel)
Nico D, de Moraes DC, Silva AC, Taveira IN, Fontes YDS, Lopes RSC, Lopes CC, Ferreira-Pereira A.   +7 more
europepmc   +1 more source

An exploration of potent antileishmanial agents derived from quinoline-thiazole and thiadiazole hybrids, targeting DHFR-TS and PTR1: design, synthesis, and computational analyses. [PDF]

RSC Med Chem
Rashdan HRM, Bekhit AA, Furlan V, Amagase K, Elshamy AI, Elfar N, Abdo MR, Ibrahim TM, Bren U, Eldehna WM, Sabt A.   +10 more
europepmc   +1 more source

Hit-Identification to Novel Antileishmanial Agents from a β‑Pinene Scaffold: from Synthesis to <i>In Vitro</i> Evaluation and <i>In Silico</i> SAR/ADMET Profiling. [PDF]

ACS Omega
Martins GDS, M da S Santos B, Emiliano YSS, Santos JPA, Machado GM, de Carvalho MS, Sette KM, Rodrigues IA, T de Souza AM, Torres-Santos EC, G Finelli F, Leal ICR.   +11 more
europepmc   +1 more source

Synthesis and biological evaluation of 4,7,9-trisubstituted benzoxazepines as antileishmanial agents. [PDF]

Bioorg Med Chem Lett
Kadayat TM, Kwiatkowski S, Ortiz D, Shoeran G, Hammill JT, Kim HS, Cholewo J, Landfear SM, Kiplin Guy R.   +8 more
europepmc   +1 more source

<i>In silico</i> target identification and pharmacokinetic profiling of 2-aryl-quinoline-4-carboxylic acid derivatives as potential antileishmanial agents. [PDF]

Front Pharmacol
da Silva MC, Viana JO, Olegário TR, Sabino JM, Barbosa EG, Chaves EJF, Rocha GB, Lima-Junior CG, Weber KC.   +8 more
europepmc   +1 more source